MedPath

Comparison between the effectiveness of methadone & Acceptance & Commitment group combination therapy & methadone therapy in the prevention rate of relapse in people with opium abuse.

Phase 2
Conditions
Mental & behavioural disorders due to use of opioids.
Mental and behavioural disorders due to use of opioids
Registration Number
IRCT2016062328603N1
Lead Sponsor
Vice chancellor for research Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
30
Inclusion Criteria

Having informed consent to participate in research; Taking at least two weeks Methadone; Being male; Having a minimum of 18 & maximum of 45 years old. Exclusion criteria: Patient will be deleted after the two meeting absence; More severe problems, such as suicidal thoughts or have psychotic disorders

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relapse prevention. Timepoint: Before the intervention, The intervention, Three months after the intervention. Method of measurement: Cravings questionnaire (DDQ), urine test kits.
Secondary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Beck Anxiety Inventory.;Depression. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Beck Depression Inventory.;Craving. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Craving Questionnaire (DDQ).;Quality of life. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Quality of Life Questionnaire (WHO).
© Copyright 2025. All Rights Reserved by MedPath